Quantum BioPharma Ltd.
General ticker "QNTM" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $7.7M (TTM average)
Quantum BioPharma Ltd. does not follow the US Stock Market performance with the rate: -5.4%.
Estimated limits based on current volatility of 14.0%: low 3.51$, high 4.65$
Factors to consider:
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.02$, 10.43$]
- 2026-12-31 to 2027-12-31 estimated range: [1.80$, 6.56$]
Short-term QNTM quotes
Long-term QNTM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $23.79MM | $16.14MM | $15.59MM |
| Operating Income | $-23.79MM | $-16.14MM | $-15.59MM |
| Non-Operating Income | $5.56MM | $1.22MM | $-11.84MM |
| Interest Expense | $0.00MM | $0.05MM | $0.63MM |
| R&D Expense | $3.86MM | $6.08MM | $2.81MM |
| Income(Loss) | $-18.23MM | $-14.92MM | $-27.43MM |
| Profit(Loss)* | $-17.90MM | $-14.20MM | $-26.63MM |
| Stockholders Equity | $13.24MM | $11.48MM | $6.91MM |
| Inventory | $0.00MM | $0.12MM | $0.05MM |
| Assets | $17.47MM | $17.12MM | $11.14MM |
| Operating Cash Flow | $-10.83MM | $-6.88MM | $-8.38MM |
| Investing Cash Flow | $-0.27MM | $-1.50MM | $-1.99MM |
| Financing Cash Flow | $-3.13MM | $11.62MM | $6.21MM |
| Earnings Per Share** | $-29.39 | $-12.49 | $-8.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.